New Key Statistics Module, Z-Score and F-Score
NAS:JAZZ Key Ratios
| Market Cap $ M | 6,854.86 |
| Enterprise Value $ M | 10,977.77 |
| P/E(ttm) | 17.96 |
| PE Ratio without NRI | 11.29 |
| Forward PE Ratio | 5.85 |
| Price/Book | 1.83 |
| Price/Sales | 1.99 |
| Price/Free Cash Flow | 7.61 |
| Price/Owner Earnings | 20.53 |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 3,834.00 |
| EPS (TTM) $ | 6.12 |
| Beneish M-Score | -2.71 |
| 10-y EBITDA Growth Rate % | 7.10 |
| 5-y EBITDA Growth Rate % | -1.50 |
| y-y EBITDA Growth Rate % | 95.30 |
| EV-to-EBIT | 18.69 |
| EV-to-EBITDA | 8.95 |
| PEG | -- |
| Shares Outstanding M | 62.35 |
| Net Margin (%) | 10.82 |
| Operating Margin % | 15.59 |
| Pre-tax Margin (%) | 7.77 |
| Quick Ratio | 1.85 |
| Current Ratio | 2.24 |
| ROA % (ttm) | 3.72 |
| ROE % (ttm) | 12.08 |
| ROIC % (ttm) | 9.25 |
| Dividend Yield % | -- |
| Altman Z-Score | 1.35 |
| Piotroski F-Score | 7.00 |
| Positive ROA | Y |
| Positive CFROA | Y |
| Higher ROA y-y | Y |
| Cash flow > Earnings | Y |
| Lower Leverage y-y | Y |
| Higher Current Ratio y-y | N |
| Less Shares Outstanding y-y | N |
| Gross Margin Increase y-y | Y |
| Higher Asset Turnover y-y | Y |
JAZZ Number of Guru Trades
JAZZ Volume of Guru Trades
Gurus Latest Trades with NAS:JAZZ
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:JAZZ is held by these investors
Total 4
Jazz Pharmaceuticals PLC Insider Transactions
No Available Data
News about NAS:JAZZ
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers